Oligonucleotide pharmaceutical composition Chimeric olignucleotide processes for modulating PKC expression in cells to detect in a sample the presence of a PKC gene or PKC MRNA to diagnose a condition associated with PKC isolated antisense oligonucleotide nucleic acid molecule having 5 to 50 nucleotides of probe comprise rocesso polynucleotides to detect a gene encoding human PKCA in a sample to detect the long MRNA transcript of human PKCA

摘要

New nucleic acid sequences are provided which encode 3' untranslated regions of human protein kinase C alpha . Compositions and methods are provided for the treatment and diagnosis of diseases associated with protein kinase C alpha . Oligonucleotides are provided which are specifically hybridizable with nucleic acid encoding PKC alpha . Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating protein kinase C expression with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to PKC are disclosed. Polynucleotide probes for PKC alpha are also disclosed.